KBR

Helixmith CEO downplays data monitoring committee's request for additional info on Engensis P3 study

Celltrion scraps development of inhaled Covid-19 antibody therapy

‘Healthcare paradigm shifts toward patient-centered care’

Chemotherapy Liporaxel gets 2-year extension of re-evaluation deadline

Policy 'Decline of new Covid-19 infections will stall but resurge is unlikely anytime soon’ Health officials said the declining trend of Covid-19 has reached its limit, predicting new infections might likely rebound in the short run."We think that the decline in the sprea...

ALL

1 Samsung Bioepis, Samil to sell Lucentis biosimilar together

2 'Treatment not enough; social perspective toward obesity needs to change'

3 Roche Korea raises sales by 30% through 'agile transformation'

4 Takeda Korea registers most patents in May

5 Korean drug companies rush to secure LNP technology

6 Regulator to update warning label for Novartis' Cosentyx over adverse events

7 Janssen confirms psoriasis treatment Tremfya binds to CD64+ cells and IL-23

8 Kangstem Biotech withdraws trial application for stem cell-based osteoarthritis treatment

[Column] Potential conflicts between new government and medical community

[Special Column on Medical Device Day] Standardization of medical device software

[Column] Korea on the march toward reimbursement for digital health

Shortage of medical examiners causes high level of burnout

Undocumented migrants unable to get health services amid pandemic

‘Can rampant hatred amid Covid-19 be strategy to curb infection risk?’

[Special] Everest Medicines confident about success in Korea

YUCM holds 45th Tropical Medicine Symposium

[Special] Antengene targets Korean oncology market with first-in-class drugs